Business Insider24m
Anatara Lifesciences Secures Funding for Key Projects
The funds will support the completion of a crucial Phase II clinical study for their GaRP medication, targeting irritable bowel syndrome, and advance an anti-obesity project. This financial move ...
Without immediate action, nearly 260 million people in the US predicted to be overweight or obese by 2050
Over the past three decades, there has been a startling increase in the prevalence of obesity across the U.S., at least ...
Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...
Anatara Lifesciences Advances Trials and Raises Capital
Anatara Lifesciences Ltd (AU:ANR) has released an update. Anatara Lifesciences is advancing its Phase II trial for GaRP in treating Irritable ...
malaymail18h
Hold my Ozempic: British Vogue editor sounds alarm over comeback of ultra-thin models
LONDON, Nov 14 — The editorial director of British Vogue magazine on Wednesday said she was worried about the return of thin ...